Illumina, INC 10-Q quarterly reports

Illumina Inc. announced its second quarter 2026 financial results, reporting a 9% increase in total revenue to $1.159 billion, driven by strong performance in consumables and instruments, alongside the integration of SomaLogic.

Illumina reported a slight revenue increase in Q3 2025 and a significant return to net income for the nine months ended September 28, 2025, despite ongoing macroeconomic and geopolitical challenges.

Illumina, Inc. reported a significant return to profitability in the second quarter of 2025, driven by the spin-off of GRAIL and absence of prior year's impairment charges, despite a 5% decline in total revenue.

Illumina's Q1 2025 revenue declined slightly, impacted by macroeconomic factors and challenges in China, while the company focuses on cost reduction and operational excellence.

Illumina reports a net income of $705 million for Q3 2024, driven by a gain from the reversal of a European Commission fine, despite a year-to-date net loss of $1.41 billion and a 3% revenue decrease.

Illumina's second quarter results show a significant net loss driven by goodwill and intangible asset impairments related to the GRAIL spin-off, despite a slight increase in gross profit.

Illumina's first quarter 2024 results show a slight revenue decrease and increased operating loss, while the company progresses with the divestiture of GRAIL.